NEW YORK (GenomeWeb News) – PerkinElmer said today that it has received Clinical Laboratory Improvement Amendments certification and a license from the State of Connecticut for its DNA Sequencing Services Laboratory in Branford.

PerkinElmer said that certification will enable it to expand its offerings to include clinical sequencing services for analysis of specific diseases including cancer and Mendelian diseases, as well as diagnostics services for new drugs and for pharmaceutical clinical trial studies.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.

Sep
17
Sponsored by
SeraCare

Today’s challenging clinical next-generation sequencing applications require a rigorous, comprehensive quality control management program to ensure confidence in results.